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INTRODUCTION
Inborn Errors of Metabolism are hereditary
affections resulting from incompetence in
enzymatic reactions of intermediary metabolism,
due both to deficiency in the enzyme involved
and to its lower activity or stability. This blockage
generally causes an increase in the precursor for
the compromised metabolic stage and a lack of
subsequent intermediaries or activation of
alternative metabolic routes, leading to the
production of substances normally not
encountered in the organism. These errors may
occur in the metabolism of all the organic
compounds, both in synthesis and catabolism
situations and in energy production, with a great
number of diseases resulting from these
metabolic disturbances.1 At present, several
hundred hereditary metabolic disturbances are
known, many of which correspond to grave
illnesses that frequently evolve to death or cause
important sequelae, especially mental deficiency.2
Considered individually, inborn
errors of metabolism present very variable
incidences. Considered as a whole, they
present a cumulative frequency of 1:500
newborns5 and are readily encountered in
medical practice.3-5 In spite of this fact, the
clinical diversity that these diseases present
makes it difficult to recognize them clinically,
with specific diagnosis being extremely
dependent on laboratory assistance.6,7
The organized study and syste-
matized planning of the diagnostic conditions
among possible inborn errors of metabolism
carriers would appear to be very promising
activities insofar as these may make it possible
to prevent and control morbidity that not long
ago was considered to be irremediable.8
Moreover, such studies open the way towards
therapy, which could be very efficacious in
some cases, with continual advances being
incorporated,9 as well as making it viable to
offer genetic counseling and assistance in the
couple’s reproductive prognosis.7,10 Within
inborn errors of metabolism diagnosis
programs, biochemical screening procedures
are of fundamental importance, as these serve
as a first indication of the general metabolic
routes that the alterations can be involved in,
and the more specific tests needed for
proceeding with the evaluation.11,12
Thus, the possibility of early detection of
carriers has motivated the screening for these
disturbances among newborns at the Neonatal
Unit of the Hospital São Paulo, in an attempt
to initiate support treatment, when available,
before clinical manifestations become evident.
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MethodS
This study was made at the Laboratory for
inborn errors of metabolism at the Center for
Medical Genetics of the Departments of
Pediatrics and Morphology of the Universidade
Federal de São Paulo/Escola Paulista de Medicina
(UNIFESP/EPM). The sample for this study was
made up by neonates born in the Hospital São
Paulo during a 14-month period.
Children were included in this study if
they fulfilled the following inclusion criteria:
presence of clinical or asymptomatic
hypoglycemia (glycemia less than 40 mg/dl),
metabolic acidosis (fall of 0.15 in pH and fall
of 10 mEq/l in bicarbonate), jaundice,
difficulty in gaining weight (weight gain <10g
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over four consecutive days, despite a calorific
offer > 100 cal/kg), diarrhea, vomiting,
hepato- and/or splenomegaly, cataracts, apnea,
convulsions, hypo- or hypertonia.
The neonatal population was classified
according to the sex, gestational age,
chronological age, and appropriateness of
weight to gestational age. The gestational age
was calculated using Naegele’s rule13 and by
Dubowitz’s method,14 performed between 6
and 24 hours after birth. The gestational age
determined by Dubowitz’s method14 was
considered when the difference between this
and the gestational age calculated using
Naegele’s rule13 was greater than two weeks,
or when the date of the last maternal
menstruation was not known, or further, when
the maternal information was imprecise.
To classify the gestational age, the World
Health Organization criteria15 were used, and
the newborns were considered to be full-term
when their gestational age ranged between 37
completed weeks and 42 uncompleted weeks,
pre-term when the gestational age was less than
37 weeks, and post-term when the gestational
age was greater than or equal to 42 weeks.
To classify the newborns according to
gestational age and birth weight, the Battaglia
& Lubchenko16 intra-uterine growth curves
were utilized. Newborns were considered to
have appropriate weight for the gestational age
when the weight was located between the 10th
and 90th percentiles of this curve. They were
considered to be large for the gestational age
when the birth weight was above the 90th
percentile, and small for the gestational age
when the weight was below the 10th percentile.
The newborns included in the study were
submitted to the tests routinely utilized in the
Laboratory for Inborn Errors of Metabolism at
the Center for Medical Genetics, based on
qualitative research for abnormal substances
excreted in the urine in situations of metabolic
disorder, as described by Buist,17 Giogio &
Luhby18 and Thomas,19 and aminoacid urine
chromatography 20.
The results from the tests were analyzed in
parallel with the clinical information available,
and in accordance with the demographic data
for the newborns obtained from consulting
their medical records from the internment in
the Neonatal Unit.
All tests with a positive result were
repeated, using a new urine sample, as a form
Table 1. Baseline characteristics
of participants
Characteristics n  (%)
Sex
Male 60 (59.4%)
Female 41 (40.6%)
Gestational Age
Pre-term 64 (63.3%)
Term 34 (33.7%)
Post-term 3 ( 3%)
Birth Weight
Small 23 (22.8%)
Appropriate 72 (71.3%)
Large 6 ( 5.9%)
Clinical Signs (Number of events#)
Hypoglycemia 62 (61.4%)
Jaundice 56 (55.4%)
Metabolic acidosis 51 (50.5%)
Respiratory disturbance 44 (43.6%)
Apnea 14 (5.3%)
Seizures 12 (13.9%)
Hepatomegaly 6 (5.9%)
Hypotonia 6 (5.9%)
Ocular alterations 5 (4.9%)
Coma 3 (2.9%)
Difficulty in gaining weight 3 (2.9%)
Vomiting 3 (2.9%)
Lethargy 1 (0.9%)
# Some patients presented more than one sign.
Table 2. Positive results for each applied test and situations
for which they are usualyusually positive
Positive situation Tests Positive results
Tyrosinemia Nitrosonaphthol 30 (29.7%)
Mucopolysaccharidosis CTA Bromide 20 (19.8%)
Mucopolysaccharidosis Toluidine Blue 1 (1.0%)
Amino aciduria Chromatographic alterations 19 (18.8%)
Reducing substances, Benedict 9 (8.9%)
particularly sugar, as in
galactosemia, fructosemia
Organic aciduria 2,4-dinitrophenyl-hydrazine 2 (2.0%)
Cystinuria – Homocystinuria Cyanide-nitroprusside 1 (1.0%)
Methylmalonic aciduria p-nitroaniline -
Phenylketonuria, tyrosinemia, Ferric Chloride -
maple syrup urine disease,
histidinemia, alkaptonuria
Table 3. Influence of gestational age and post-natal age on test positivity, expressed as
number of newborns with positive tests
Gestational age Post-natal age
1 to 7 days 8 to 14 days > 14 days Total
Pre-term 26 (40.6%) 14 (21.9%) 5 (7.8%) 45 (70.3%)
Full and post-Term 13 (20.3%) 3 (4.7%) 3 (4.7%) 19 (29.7%)
Total 39 (60.9%) 17 ( 26.6%) 8 (12.5%) 64 (100.0%)
c 2= 0.63; (g.l. = 4); P = 0.89.
of follow-up for these newborns. In the same
way, all the newborns that persisted with the
clinical alterations cited in the inclusion
criteria for the study, but presented normal
results in the first tests performed, had their
tests repeated.
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RESULTS
The sample studied was made up of 101
newborns selected from among the births
occurring at the Neonatal Unit during a 14
month period, representing 6.8% of the total
number of births during the period (n = 1477).
These newborns were predominantly
male, premature and with weight appropriate
to the gestational age (Table 1). They were
included in the study mainly because of the
development of hypoglycemia, jaundice or
metabolic acidosis (Table 2) and the majority
were submitted to screening tests in the first
week of life (61.4%).
Of these newborns, 63.4% presented at least
one positive test result. The individual results of
the tests are shown in Table 3, along with the
conditions for them to be positive.17,18,21
Table 3 shows the characteristics of the
newborns that may be related to the presentation
of a positive result in the tests applied, compared
using the chi-squared (c2) test.
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The majority of the positive results were
observed in premature patients (c2 = 3.55) and
in those submitted to tests in the first week of
life (c2 = 2.56), even though these differences
were not statistically significant. The association
of both conditions in the newborns with positive
results was not significant (c2 = 0.63) (Table 3).
For three of the patients studied, the tests
applied permitted us to formulate a diagnostic
hypothesis  with greater confidence, respectively
of mucopolysaccharidosis, tyrosinemia type I
and non-ketotic hyperglycinemia, as will be
seen in the discussion, although these tests alone
did not confirm the diagnosis.
Regarding two other infants referred
onwards, the diagnostic hypotheses were made
mainly from the clinical findings. and the
family history. One of them, included in the
study because of presenting convulsive crises
and hepatosplenomegaly, whose screening
tests that were all normal, had two deceased
sisters whose clinical state had included
convulsions, loss of learned skills and hepatic
insufficiency, for whom a diagnostic
hypothesis of Alpers’ Syndrome had been
proposed. The second child mentioned, the
daughter of consanguineous parents,
presented cyanosis, vomiting, tremor (without
presenting hypoglycemia), convulsions, apnea,
bradycardia, hypotonia and microcephaly.
This child also had screening tests with normal
results and had a family history of two
deceased brothers with the same clinical
condition. For this child, a diagnostic
hypothesis of pyruvate dehydrogenase
complex deficiency was put forward.
The other four children referred all
presented persistent metabolic acidosis, two
of whom also presented convulsive crises. For
one of these, a low protein diet was introduced
during its internment in the Neonatal Unit,
which reversed the metabolic acidosis
condition. In none of these four patients did
the screening tests permit the establishment
of a diagnostic hypothesis.
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DISCUSSION
Among the 101 newborns studied,
approximately 63% presented a positive result
in at least one of the tests to which they were
submitted.  Of all the tests applied, three merit
highlighting because of the large numbers of
positive results.
The cetyltrimethyl-ammonium bromide test,
utilized for the detection of glycosaminoglycans
in the urine, was a test that presented a great
number of false-positive results. It was positive in
situations in which the newborn also presented a
positive result for other substances not normally
encountered in urine, such as reducing substances,
or an altered pattern of amino acid excretion in
the urine. For this reason, this test was utilized as
an indicator for performing the toluidine blue test,
a more specific test for the detection of
glycosaminoglycans in the urine. With this latter
test, only one positive result was found and in
this case, there was an indication for the follow-
up of the patient for investigation of
mucopolysaccharidosis.
In addition to the cetyltrimethyl-
ammonium bromide test, the nitrosonaphthol
test (specific for the detection of tyrosine and
an excess of its metabolites in urine) also
presented large positivity (29.7%), which we
did not, however, consider to be a false-positive
result. We believe that these are related to the
newborn’s own metabolic immaturity, especially
when compared to the positivity of this test in
examinations performed routinely at the
Laboratory for Inborn Errors of Metabolism
at the Center for Medical Genetics, which is
only 1.0% (N = 1000).
These positive tests would indicate cases of
transitory neonatal tyrosinemia. This condition
is believed to be the most common alteration in
the metabolism of amino acids in human beings,
with an incidence of 10% having been described
among full-term newborns and between 30 and
50% among premature newborns.22 This
condition does not have an exclusive genetic
determination (late maturation of hydroxyphenyl-
pyruvate dehydrogenase and tyrosine amino
transferase),26 but is also related to prematurity,
high protein ingestion during the first days of
life (> 3 g of protein/kg weight), low birth weight,
low ingestion of vitamin C (a cofactor in
compromised metabolic routes), among other
factors.22-26
Transitory Neonatal Tyrosinemia is
considered to be a benign condition, although
there is a lack of recent studies to confirm this
information.27 In older studies, a reduction in
motor activity of these newborns was observed
in relation to normal controls paired by
gestational and post-natal ages,28 lethargy,25
and an intellectual deficit in children assessed
around the ages of 4 to 5 years,29 although
another study did not show any neurological
or developmental alteration in children with
transitory neonatal tyrosinemia assessed at 2
years of age. Nevertheless, greater morbidity
was observed among these children, especially
related to the respiratory system.30
Recently, Jardim et al.31 evaluated children
presenting transitory neonatal tyrosinemia at
4 years of age, observing slight intellectual
deficits in these children in comparison with
the control group. In this same study, a
possible association of this condition with
behavioral problems such as attention deficit
and hyperactivity was suggested.
In our sample, the newborns that
presented this condition were predominantly
premature (80.0%), born with weight
appropriate to the gestational age (70.0%),
submitted to screening tests within the first
two weeks of life (93.3%) and presented
metabolic acidosis (73.3%), respiratory
insufficiency (60.0%), hypoglycemia (56.7%),
jaundice (53.3%) and sepsis (46.7%) during
hospital internment.
When they presented a positive result in
the nitrosonaphthol test, the newborns received
oral supplements of vitamin C (100 mg/day)22
and had their test repeated after approximately
one week, so that the transitoriness of the
disturbance could be confirmed. Only one
result continued to be positive after the
repetition of the test, and the patient was
referred to the Genetic Unit with a diagnostic
hypothesis of tyrosinemia type I.
Regarding the alterations on aminoacid urine
chromatograms, the majority of them were
transitory alterations, except for one patient who
continued with increased excretion in the glycine
migration band, which is being followed up with
a diagnostic hypothesis of non-ketotic
hyperglycinemia.
As in the case of hypertyrosinemia, these
transitory alterations are a result of the
newborn’s own immaturity, which is known
to be capable of causing alterations in the
excretion of various aminoacids.32 They have
the same contributory factors, i.e.
prematurity, low weight, the quantity and
quality of the diet, the rate of growth and
renal immaturity.33, 34
Although we selected 9% of the patients
for outpatient follow-up, these patients are still
proceeding with investigations to confirm the
diagnosis. Our percentage of selected
individuals for further investigation is greater
than that found in other studies made on
selected populations in Brazil, which have
shown inborn errors of metabolism detection
rates of between 6.5 and 7.7%.35-38 On the
other hand, a more recent work from
Sanseverino et al.11 detected a 13% rate of
inborn errors of metabolism in patients from
pediatric and neonatal intensive care units
with more similarities to the group of patients
we studied.
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CONCLUSION
The high positivity observed in the
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screening tests is of fundamental importance
for directing the clinical investigation, especially
in places where more specific examinations are
unavailable. It depends on an intimate
association between the interpretation of the
biochemical tests and a specialized multi-
disciplinary clinical investigation.
The selection of 9% of the screened cases for
outpatient follow-up confirms that inborn errors
of metabolism must be suspected whenever a
patient presents metabolic disturbances or
neurological manifestations without a determined
cause. They should be researched in parallel with
the other diagnostic possibilities and not just taken
to be exceptional diagnoses.
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CONTEXTO: Os erros inatos do metabolismo são
afecções hereditárias resultantes da
incompetência de reações do metabolismo
intermediário. Atualmente já são conhecidos
centenas de distúrbios metabólicos hereditários,
muitos deles correspondendo a enfermidades
graves que evoluem com freqüência para o óbito,
ou causam seqüelas importantes, princi-
palmente a deficiência mental.
OBJETIVO: A possibilidade de detecção precoce
de portadores motivou a triagem desses
distúrbios entre recém-nascidos da Unidade
Neonatal, na tentativa de iniciar o tratamento
de suporte, quando disponível, antes que as
manifestações clínicas fossem evidentes.
TIPO DE ESTUDO:  Estudo prospectivo.
LOCAL: Unidade Neonatal em Hospital
Terciário.
PARTICIPANTES: 101 crianças internadas na
Unidade neonatal foram incluídas no estudo
por apresentarem hipoglicemia, acidose
metabólica, icterícia, dificuldade de ganhar
peso, diarréia, vômitos, hepato e/ou esple-
nomegalia, catarata, apnéia, convulsões, hipo
ou hipertonia.
TESTES APLICADOS: Testes realizados para
pesquisa qualitativa de substâncias anor-
malmente excretadas na urina em situações
de desordem metabólica.
RESULTADOS: Os recém-nascidos foram
incluídos no estudo principalmente por
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RESUMO
apresentarem hipoglicemia, icterícia e acidose
metabólica. 64 recém-nascidos apresentaram
pelo menos um teste com resultado positivo.
A positividade foi devida principalmente a
distúrbios metabólicos transitórios, como por
exemplo a Tirosinemia Transitória do Recém-
Nascido, apresentada por 29 pacientes. Nove
crianças foram selecionadas e encaminhadas
ao Centro Medico de Genética para con-
tinuação da investigação diagnóstica. Para três
delas os testes aplicados permitiram a
formulação de uma hipótese diagnóstica de
mucopolissacaridose, tirosinemia tipo I e
hiperglicinemia não-cetótica, respectivamente.
CONCLUSÕES: A alta positividade observada
nos testes reflete a imaturidade metabólica
própria do recém-nascido. A seleção de 9%
dos casos triados para acompanhamento
ambulatorial confirma que os erros inatos do
metabolismo devem ser suspeitados sempre
que um paciente apresente distúrbios
metabólicos ou manifestações neurológicas
sem causa determinada, sendo pesquisados
paralelamente às demais possibilidades
diagnósticas e não apenas tidos como
diagnósticos de exceção.
PALAVRAS-CHAVE:  Erros inatos do
metabolismo. Distúrbios metabólicos
hereditários. Recém-nascidos. Triagem
urinária.
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